Jacobio Pharmaceuticals Group Co., Ltd.
HKEX:1167.HK
1.82 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 1,143.126 | 1,283.598 | 1,527.204 | 1,627.408 | 314.338 | 420.833 |
| Short Term Investments
| 50.013 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 1,143.126 | 1,283.598 | 1,527.204 | 1,627.408 | 314.338 | 420.833 |
| Net Receivables
| 9.339 | 15.033 | 64.919 | 171.413 | 0 | 0 |
| Inventory
| 4.721 | 0 | 10.379 | 0 | 0 | 0 |
| Other Current Assets
| 11.224 | 25.026 | 37.225 | 16.527 | 3.746 | 4.198 |
| Total Current Assets
| 1,168.41 | 1,338.747 | 1,639.727 | 1,815.348 | 318.084 | 425.031 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 219.603 | 205.228 | 41.772 | 34.129 | 34.03 | 35.287 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 1.366 | 1.019 | 1.548 | 1.171 | 0 | 3.889 |
| Goodwill and Intangible Assets
| 1.366 | 1.019 | 1.548 | 1.171 | 0 | 3.889 |
| Long Term Investments
| 18.181 | 25.421 | 16.228 | 0 | 0 | 0 |
| Tax Assets
| 0 | -25.421 | -16.228 | 0 | 0 | 0 |
| Other Non-Current Assets
| 52.921 | 29.653 | 38.787 | 16.702 | 11.213 | 9.389 |
| Total Non-Current Assets
| 292.071 | 235.9 | 82.107 | 52.002 | 45.243 | 48.565 |
| Total Assets
| 1,460.481 | 1,574.647 | 1,721.834 | 1,867.35 | 363.327 | 473.596 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 81.191 | 96.551 | 51.047 | 28.281 | 12.737 | 9.002 |
| Short Term Debt
| 87.945 | 13.131 | 4.918 | 8.637 | 9.719 | 0 |
| Tax Payables
| 1.936 | 2.353 | 1.967 | 1.734 | 0.942 | 0.419 |
| Deferred Revenue
| -14.329 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 50.323 | 46.169 | 24.868 | 36.96 | 23.265 | 8.963 |
| Total Current Liabilities
| 205.13 | 155.851 | 80.833 | 73.878 | 45.721 | 17.965 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 121.969 | 134.663 | 1.889 | 2.011 | 10.807 | 15.467 |
| Deferred Revenue Non-Current
| 1.194 | 1.609 | 2.024 | 5.261 | 6.612 | 8.442 |
| Deferred Tax Liabilities Non-Current
| 0 | -1.609 | -2.024 | -5.261 | 0 | -15.467 |
| Other Non-Current Liabilities
| 58.817 | 1.609 | 2.024 | 5.261 | 770.265 | 544.434 |
| Total Non-Current Liabilities
| 181.98 | 136.272 | 3.913 | 7.272 | 787.684 | 552.876 |
| Total Liabilities
| 387.11 | 292.123 | 84.746 | 81.15 | 833.405 | 570.841 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 1.88 |
| Common Stock
| 0.523 | 0.51 | 0.51 | 0.502 | 0.03 | 0.03 |
| Retained Earnings
| -3,193.799 | -2,834.68 | -2,462.819 | -2,161.632 | -636.117 | -211.306 |
| Accumulated Other Comprehensive Income/Loss
| 4,266.647 | 4,116.694 | 4,099.397 | 3,947.33 | 166.278 | -12.03 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 126.061 |
| Total Shareholders Equity
| 1,073.371 | 1,282.524 | 1,637.088 | 1,786.2 | -469.809 | -95.365 |
| Total Equity
| 1,073.371 | 1,282.524 | 1,637.088 | 1,786.2 | -470.078 | -97.245 |
| Total Liabilities & Shareholders Equity
| 1,460.481 | 1,574.647 | 1,721.834 | 1,867.35 | 363.327 | 473.596 |